US Stock MarketDetailed Quotes

CRXWQ CLARUS THERAPEUTICS HLDGS INC C/WTS 11/08/2026 (TO PUR COM)

Watchlist

0.000
0.0000.00%

15min DelayClose Mar 1 16:00 ET

0Market Cap0.00P/E (TTM)

CLARUS THERAPEUTICS HLDGS INC C/WTS 11/08/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-17.51%-17.5M

-145.21%-17.27M

-5.31%-43.79M

-57.70%-9.33M

-12.52M

-14.89M

-7.04M

-41.58M

-5.92M

Net income from continuing operations

40.97%-10.69M

3.62%-14.87M

-1,034.80%-40.62M

-1,647.48%-4.3M

---2.77M

---18.12M

---15.43M

--4.35M

--278K

Operating gains losses

---728K

---642K

80.86%-12.8M

62.43%-4.9M

----

---66.89M

---13.04M

Depreciation and amortization

0.00%7K

40.00%7K

38.89%25K

75.00%7K

--6K

--7K

--5K

--18K

--4K

Other non cash items

-58.58%2.02M

-181.57%-3.79M

29.95%16.19M

-58.11%1.93M

--4.75M

--4.88M

--4.64M

--12.46M

--4.6M

Change In working capital

-365.56%-8.56M

-55.41%1.59M

-194.57%-7.25M

-232.58%-2.18M

---6.8M

---1.84M

--3.57M

--7.66M

--1.64M

-Change in receivables

30.21%-700K

-101.70%-1.66M

55.89%-1.94M

162.28%591K

---704K

---1M

---825K

---4.4M

---949K

-Change in inventory

-8.63%-1.88M

67.11%-716K

-856.97%-8.36M

-584.64%-1.74M

---2.72M

---1.73M

---2.18M

--1.1M

--358K

-Change in prepaid assets

39.85%186K

205.45%290K

-251.99%-2.83M

-1,017.14%-782K

---1.91M

--133K

---275K

---804K

---70K

-Change in payables and accrued expense

-990.31%-7.17M

-52.55%3.28M

-48.39%5.47M

-157.66%-1.01M

---1.25M

--805K

--6.92M

--10.59M

--1.75M

-Change in other working capital

2,225.53%999K

607.69%396K

-64.76%413K

37.07%758K

---220K

---47K

---78K

--1.17M

--553K

Cash from discontinued investing activities

Operating cash flow

-17.51%-17.5M

-145.21%-17.27M

-5.31%-43.79M

-57.70%-9.33M

---12.52M

---14.89M

---7.04M

---41.58M

---5.92M

Investing cash flow

Cash flow from continuing investing activities

9.09%-10K

60.32%-25K

-400.00%-5K

-9K

-11K

-63K

-1K

Net PPE purchase and sale

--0

9.09%-10K

60.32%-25K

-400.00%-5K

--0

---9K

---11K

---63K

---1K

Cash from discontinued investing activities

Investing cash flow

--0

9.09%-10K

60.32%-25K

-400.00%-5K

--0

---9K

---11K

---63K

---1K

Financing cash flow

Cash flow from continuing financing activities

54.56%27.54M

33.40%62.99M

13.8M

24.19M

17.82M

7.18M

47.22M

Net issuance payments of debt

--0

-36.57%32.18M

---1K

--7.18M

--17.82M

--7.18M

--50.74M

--0

Net common stock issuance

----

--13.8M

----

--0

----

Net other financing activities

----

583.76%17.01M

--1K

----

---3.52M

--0

Cash from discontinued financing activities

Financing cash flow

54.56%27.54M

--0

33.40%62.99M

--13.8M

--24.19M

--17.82M

--7.18M

--47.22M

--0

Net cash flow

Beginning cash position

24.08%9.14M

265.20%26.42M

336.78%7.23M

66.90%21.95M

--10.28M

--7.36M

--7.23M

--1.66M

--13.15M

Current changes in cash

244.41%10.04M

-13,289.31%-17.28M

243.95%19.18M

175.37%4.46M

--11.68M

--2.91M

--131K

--5.58M

---5.92M

End cash Position

86.54%19.17M

24.08%9.14M

265.20%26.42M

--21.95M

--10.28M

--7.36M

--7.23M

Free cash flow

-17.44%-17.5M

-144.97%-17.28M

-5.21%-43.81M

-57.75%-9.34M

---12.52M

---14.9M

---7.05M

---41.64M

---5.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-17.51%-17.5M	-145.21%-17.27M	-5.31%-43.79M	-57.70%-9.33M	-12.52M	-14.89M	-7.04M	-41.58M	-5.92M
Net income from continuing operations	40.97%-10.69M	3.62%-14.87M	-1,034.80%-40.62M	-1,647.48%-4.3M	---2.77M	---18.12M	---15.43M	--4.35M	--278K
Operating gains losses	---728K	---642K	80.86%-12.8M	62.43%-4.9M	----	----	----	---66.89M	---13.04M
Depreciation and amortization	0.00%7K	40.00%7K	38.89%25K	75.00%7K	--6K	--7K	--5K	--18K	--4K
Other non cash items	-58.58%2.02M	-181.57%-3.79M	29.95%16.19M	-58.11%1.93M	--4.75M	--4.88M	--4.64M	--12.46M	--4.6M
Change In working capital	-365.56%-8.56M	-55.41%1.59M	-194.57%-7.25M	-232.58%-2.18M	---6.8M	---1.84M	--3.57M	--7.66M	--1.64M
-Change in receivables	30.21%-700K	-101.70%-1.66M	55.89%-1.94M	162.28%591K	---704K	---1M	---825K	---4.4M	---949K
-Change in inventory	-8.63%-1.88M	67.11%-716K	-856.97%-8.36M	-584.64%-1.74M	---2.72M	---1.73M	---2.18M	--1.1M	--358K
-Change in prepaid assets	39.85%186K	205.45%290K	-251.99%-2.83M	-1,017.14%-782K	---1.91M	--133K	---275K	---804K	---70K
-Change in payables and accrued expense	-990.31%-7.17M	-52.55%3.28M	-48.39%5.47M	-157.66%-1.01M	---1.25M	--805K	--6.92M	--10.59M	--1.75M
-Change in other working capital	2,225.53%999K	607.69%396K	-64.76%413K	37.07%758K	---220K	---47K	---78K	--1.17M	--553K
Cash from discontinued investing activities
Operating cash flow	-17.51%-17.5M	-145.21%-17.27M	-5.31%-43.79M	-57.70%-9.33M	---12.52M	---14.89M	---7.04M	---41.58M	---5.92M
Investing cash flow
Cash flow from continuing investing activities	0	9.09%-10K	60.32%-25K	-400.00%-5K	0	-9K	-11K	-63K	-1K
Net PPE purchase and sale	--0	9.09%-10K	60.32%-25K	-400.00%-5K	--0	---9K	---11K	---63K	---1K
Cash from discontinued investing activities
Investing cash flow	--0	9.09%-10K	60.32%-25K	-400.00%-5K	--0	---9K	---11K	---63K	---1K
Financing cash flow
Cash flow from continuing financing activities	54.56%27.54M	0	33.40%62.99M	13.8M	24.19M	17.82M	7.18M	47.22M	0
Net issuance payments of debt	--0	--0	-36.57%32.18M	---1K	--7.18M	--17.82M	--7.18M	--50.74M	--0
Net common stock issuance	----	----	--13.8M	----	----	----	----	--0	----
Net other financing activities	----	----	583.76%17.01M	--1K	----	----	----	---3.52M	--0
Cash from discontinued financing activities
Financing cash flow	54.56%27.54M	--0	33.40%62.99M	--13.8M	--24.19M	--17.82M	--7.18M	--47.22M	--0
Net cash flow
Beginning cash position	24.08%9.14M	265.20%26.42M	336.78%7.23M	66.90%21.95M	--10.28M	--7.36M	--7.23M	--1.66M	--13.15M
Current changes in cash	244.41%10.04M	-13,289.31%-17.28M	243.95%19.18M	175.37%4.46M	--11.68M	--2.91M	--131K	--5.58M	---5.92M
End cash Position	86.54%19.17M	24.08%9.14M	265.20%26.42M	265.20%26.42M	--21.95M	--10.28M	--7.36M	--7.23M	--7.23M
Free cash flow	-17.44%-17.5M	-144.97%-17.28M	-5.21%-43.81M	-57.75%-9.34M	---12.52M	---14.9M	---7.05M	---41.64M	---5.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall